SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?


To: AlienTech who wrote (13049)8/11/1998 12:41:00 PM
From: Mkilloran  Respond to of 23519
 
alien...I think your reading the tea leaves wrong.....

If they did a private placement they would not put these shares in a margin acct available for more shorts...they would be for the long haul ...a large pharm like JNJ or Astra...paying cash to feed vivus to keep them alive. They would be buying the shares for something greater than the market share of $5 and change...

Wait for clarification or news event to clear the air...



To: AlienTech who wrote (13049)8/11/1998 12:42:00 PM
From: VLAD  Read Replies (2) | Respond to of 23519
 
alien,

You are wrong about a few things. If these shares were sold as an equity stake then they probably won't be available for shorting. Also, wouldn't Vivus have to inform the shareholders BEFORE releasing these shares.